Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  4SC AG    VSC   DE000A14KL72

4SC AG

(VSC)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

4SC AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/19/2019 | 07:35am EST

DGAP Voting Rights Announcement: 4SC AG
4SC AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
19.11.2019 / 13:32
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: 4SC AG
Street: Fraunhoferstr. 22
Postal code: 82152
City: Planegg-Martinsried
Germany
Legal Entity Identifier (LEI): 391200QOKN7LGVP0RQ86

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
X Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Natural person (first name, surname): Wolfgang Egger
Date of birth: 18 Aug 1965

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
14 Nov 2019

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 4.03 % % 4.03 % 4.03
Previous notification 6.05 % % 6.05 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A14KL72 1854158 % 4.03 %
Total 1854158 4.03 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Wolfgang Egger % % %
WE Vermögensverwaltungs GmbH & Co. KG % % %
First Capital Partner GmbH % % %
FCP Anlage AG % % %
 
Wolfgang Egger % % %
WE Vermögensverwaltungs GmbH & Co. KG % % %
First Capital Partner GmbH % % %
FCP Biotech Holding GmbH % % %
 
Wolfgang Egger % % %
WE Verwaltungs GmbH % % %
WE Vermögensverwaltungs GmbH & Co. KG % % %
First Capital Partner GmbH % % %
FCP Anlage AG % % %
 
Wolfgang Egger % % %
WE Verwaltungs GmbH % % %
WE Vermögensverwaltungs GmbH & Co. KG % % %
First Capital Partner GmbH % % %
FCP Biotech Holding GmbH % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
19 Nov 2019



19.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: 4SC AG
Fraunhoferstr. 22
82152 Planegg-Martinsried
Germany
Internet: www.4sc.com

 
End of News DGAP News Service

916305  19.11.2019 

fncls.ssp?fn=show_t_gif&application_id=916305&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on 4SC AG
01/154SC AG : First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the N..
EQ
01/094SC AG : 3 upcoming conferences
EQ
01/074SC : enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany ..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Preliminary announcement of the publication of quarterly reports and qu..
EQ
20194SC AG : Preliminary announcement of the publication of financial reports accord..
EQ
20194SC AG : Positive safety review of Phase Ib/II EMERGE study of domatinostat + av..
EQ
20194SC AG : Correction of a release from 19/11/2019 according to Article 40, Sectio..
EQ
20194SC AG : Release according to Article 40, Section 1 of the WpHG [the German Secu..
EQ
20194SC AG : Release according to Article 41 of the WpHG [the German Securities Trad..
EQ
More news
Financials (EUR)
Sales 2019 -
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 -
Capi. / Sales2020 -
Capitalization 112 M
Chart 4SC AG
Duration : Period :
4SC AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 4SC AG
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 2,43  
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Jason Loveridge Chief Executive Officer
Clemens M. Doppler Chairman-Supervisory Board
Susanne Danhauser-Riedl Chief Medical Officer
Manfred Rüdiger Member-Supervisory Board
Helmut Jeggle Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
4SC AG15.17%124
IQVIA HOLDINGS INC.4.53%31 339
LONZA GROUP3.82%28 010
CELLTRION, INC.--.--%20 141
SEATTLE GENETICS, INC.-4.60%18 681
INCYTE CORPORATION-7.81%17 339